HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q1 2024 | 1,000 | $3.77K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,000 | $3.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,000 | $3.28K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,000 | $4.48K | <0.1% | +1,000 | New | Holders |